Unique and differential protein signatures within the mononuclear cells of HIV-1 and hcv mono-infected and co-infected patients

Clinical Proteomics

Volumn 9, Issue 1, 2012, Pages

  Boukli, Nawal M ^a   Shetty, Vivekananda ^b   Cubano, Luis ^a   Ricaurte, Martha ^a   Coelho Dos Reis, Jordana ^c   Nickens, Zacharie ^b   Shah, Punit ^b   Talal, Andrew H ^d   Philip, Ramila ^b   Jain, Pooja ^c  

^a SCHOOL OF MEDICINE   (Puerto Rico)

^b Immunotope Inc   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

2D GE; HCV; HIV 1; HIV 1 HCV; Mass spectrometry; Pro and anti apoptotic fingerprinting; Proteomics

Indexed keywords

CHAPERONE; CYTOSKELETON PROTEIN; GELSOLIN; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 90; PROFILIN I; PROTEIN DYPLSL3; PROTEIN DYPLSL4; RAN PROTEIN; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; TROPOMYOSIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; GEL ELECTROPHORESIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED INFECTION; MONONUCLEAR CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; UPREGULATION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84887285004     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-9-11     Document Type: Article

References (59)

1. Franciscus A, Highleyman L: HIV/HCV Coinfection. Hepatitis C Support Project Factsheet 2007:2.
2. Matthews GV, Dore GJ: HIV and hepatitis C coinfection. J Gastroenterol Hepatol 2008, 23:1000-1008. (Pubitemid 352019390)
3. Roe B, Coughlan S, Hassan J, Grogan A, Farrell G, Norris S, Bergin C, Hall WW: Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis 2007, 196:1053-1057. (Pubitemid 47580300)
4. Ostapowicz G, Watson KJ, Locarnini SA, Desmond PV: Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998, 27:1730-1735. (Pubitemid 28264702)
5. Balasubramanian A, Groopman JE, Ganju RK: Underlying pathophysiology of HCV infection in HIV-positive drug users. J Addict Dis 2008, 27:75-82.
6. Zhang L, Jia X, Zhang X, Sun J, Peng X, Qi T, Ma F, Yin L, Yao Y, Qiu C, Lu H: Proteomic analysis of PBMCs: Characterization of potential HIV-associated proteins. Proteome Sci 2010, 8:12.
7. List EO, Berryman DE, Bower B, Sackmann-Sala L, Gosney E, Ding J, Okada S, Kopchick JJ: The use of proteomics to study infectious diseases. Infect Disord Drug Targets 2008, 8:31-45. (Pubitemid 351663635)
8. Luciano-Montalvo C, Ciborowski P, Duan F, Gendelman HE, Melendez LM: Proteomic analyses associate cystatin B with restricted HIV-1 replication in placental macrophages. Placenta 2008, 29:1016-1023.
9. Jason TB, Smeaton L, Hiasa Y, Horiike N, Onji M, Jamieson DJ, Rodriguez I, Mayer KH, Chung RT: Detection of Hepatitis C Virus (HCV) in Serum and Peripheral-Blood Mononuclear Cells from HCV-Monoinfected and HIV/HCV-Coinfected Persons. The Journal of Infectious Diseases 2005, 192:258-265. (Pubitemid 40993395)
10. Kaiser P, Niederost B, Joos B, von Wyl V, Opravil M, Weber R, Gunthard HF, Fischer M: Equal amounts of intracellular and virion-enclosed hepatitis C virus RNA are associated with peripheral-blood mononuclear cells in vivo. J Infect Dis 2006, 194:1713-1723. (Pubitemid 44902003)
11. Pal S, Sullivan DG, Kim S, Lai KK, Kae J, Cotler SJ, Carithers RL Jr, Wood BL, Perkins JD, Gretch DR: Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 2006, 130:1107-1116.
12. Laskus T, Operskalski EA, Radkowski M, Wilkinson J, Mack WJ, de Giacomo M, Al-Harthi L, Chen Z, Xu J, Kovacs A: Negative-Strand Hepatitis C Virus (HCV) RNA in Peripheral Blood Mononuclear Cells from Anti-HCV-Positive/HIV-Infected Women. Journal of Infectious Diseases 2007, 195:124-133. (Pubitemid 44958234)
13. Pham TN, King D, Macparland SA, McGrath JS, Reddy SB, Bursey FR, Michalak TI: Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008, 134:812-822. (Pubitemid 351312726)
14. Laskus T, Radkowski M, Wang LF, Nowicki M, Rakela J: Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: Confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. Journal of virology 2000, 74:1014-1017. (Pubitemid 30036240)
15. Roque-Afonso A-M, Ducoulombier D, Di Liberto G, Kara R, Gigou M, Dussaix E, Samuel D, Feray C: Compartmentalization of Hepatitis C Virus Genotypes between Plasma and Peripheral Blood Mononuclear Cells. J Virol 2005, 79:6349-6357. (Pubitemid 40617238)
16. Roque Afonso AM, Jiang J, Penin F, Tareau C, Samuel D, Petit MA, Bismuth H, Dussaix E, Feray C: Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. Journal of virology 1999, 73:9213-9221. (Pubitemid 29487076)
17. Pham TNQ, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI: Hepatitis C Virus Persistence after Spontaneous or Treatment-Induced Resolution of Hepatitis C. J Virol 2004, 78:5867-5874. (Pubitemid 38661674)
18. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T: Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005, 41:106-114. (Pubitemid 40066388)
19. Carreño V, Pardo M, López-Alcorocho JM, Rodríguez- Iñigo E, Bartolomé J, Castillo I: Detection of Hepatitis C Virus (HCV) RNA in the Liver of Healthy, Anti-HCV Antibody-Positive, Serum HCV RNA-Negative Patients with Normal Alanine Aminotransferase Levels. Journal of Infectious Diseases 2006, 194:53-60.
20. De Felipe B, Leal M, Soriano-Sarabia N, Gutiérrez A, López-Cortés L, Molina-Pinelo S, Vallejo A: HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse. Journal of Viral Hepatitis 2009, 16:21-27.
21. Lee WM, Polson JE, Carney DS, Sahin B, Gale M Jr: Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 2005, 192:1088-1092. (Pubitemid 41266808)
22. Lin A, Thadareddy A, Goldstein MJ, Lake-Bakaar G: Immune suppression leading to hepatitis C virus re-emergence after sustained virological response. Journal of medical virology 2008, 80:1720-1722.
23. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study. Lancet 2001, 357:1069-1075. (Pubitemid 32322537)
24. Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ: Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology 2004, 127:1704-1713. (Pubitemid 39575849)
25. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, SS M, Torriani FJ, Dieterich DT, Thomas DL, et al: Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006, 43:1317-1325. (Pubitemid 43980111)
26. Suzman DL, McLaughlin M, Hu Z, Kleiner DE, Wood B, Lempicki RA, Mican JM, Suffredini A, Masur H, Polis MA, Kottilil S: Identification of novel markers for liver fibrosis in HIV/hepatitis C virus coinfected individuals using genomics-based approach. AIDS 2008, 22:1433-1439.
27. Chen DS, Sung JL, Sheu JC, Lai MY, How SW, Hsu HC, Lee CS, Wei TC: Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 1984, 86:1404-1409. (Pubitemid 14147930)
28. Buamah PK, Gibb I, Bates G, Ward AM: Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries. Clin Chim Acta 1984, 139:313-316. (Pubitemid 14111450)
29. Toro-Nieves DM, Rodriguez Y, Plaud M, Ciborowski P, Duan F, Perez Laspiur J, Wojna V, Melendez LM: Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment. J Neurovirol 2009, 15:36-50.
30. Singer EJ: Patient page. A new clue in the mystery of neuro-AIDS. Neurology 2003, 60:12-13.
31. Jain P, Ahuja J, Khan ZK, Shimizu S, Meucci O, Jennings SR, Wigdahl B: Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1. J Leukoc Biol 2007, 82:44-56. (Pubitemid 47026415)
32. Bromberg Y, Shani E, Joseph G, Gorzalczany Y, Sperling O, Pick E: The GDP bound form of the small G protein Rac1 p21 is a potent activator of the superoxide-forming NADPH oxidase of macrophages. J Biol Chem 1994, 269:7055-7058. (Pubitemid 24217883)
33. Shin JY, Hur W, Wang JS, Jang JW, Kim CW, Bae SH, Jang SK, Yang SH, Sung YC, Kwon OJ, Yoon SK: HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med 2005, 37:138-145. (Pubitemid 40676924)
34. Schacker TW, Nguyen PL, Beilman GJ, Wolinsky S, Larson M, Reilly C, Haase AT: Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 2002, 110:1133-1139. (Pubitemid 35215894)
35. Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, Christensen PB, Nielsen H, Moller A, Sorensen HT, Obel N: Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: A nationwide cohort study. Clin Infect Dis 2006, 42:1481-1487.
36. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P, Haugen A: Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997, 18:1285-1289. (Pubitemid 28134699)
37. Gunning P, O'Neill G, Hardeman E: Tropomyosin-based regulation of the actin cytoskeleton in time and space. Physiol Rev 2008, 88:1-35.
38. Pittenger MF, Kazzaz JA, Helfman DM: Functional properties of non-muscle tropomyosin isoforms. Curr Opin Cell Biol 1994, 6:96-104. (Pubitemid 24048701)
39. Jimenez-Baranda S, Gomez-Mouton C, Rojas A, Martinez-Prats L, Mira E, Ana Lacalle R, Valencia A, Dimitrov DS, Viola A, Delgado R, et al: Filamin-A regulates actin-dependent clustering of HIV receptors. Nat Cell Biol 2007, 9:838-846. (Pubitemid 47019471)
40. Theriot JA, Mitchison TJ: The three faces of profilin. Cell 1993, 75:835-838. (Pubitemid 24014540)
41. Ricardo-Dukelow M, Kadiu I, Rozek W, Schlautman J, Persidsky Y, Ciborowski P, Kanmogne GD, Gendelman HE: HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J Neuroimmunol 2007, 185:37-46. (Pubitemid 46497432)
42. Bergmeier LA, Babaahmady K, Pido-Lopez J, Heesom KJ, Kelly CG, Lehner T: Cytoskeletal proteins bound to heat-shock protein 70 may elicit resistance to simian immunodeficiency virus infection of CD4(+) T cells. Immunology 2010, 129:506-515.
43. Howell AL, Groveman DS, Wallace PK, Fanger MW: HIV-1-infected monocytes and monocyte-derived macrophages are impaired in their ability to produce superoxide radicals. Int J Clin Lab Res 1997, 27:111-117.
44. Persidsky Y, Heilman D, Haorah J, Zelivyanskaya M, Persidsky R, Weber GA, Shimokawa H, Kaibuchi K, Ikezu T: Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 2006, 107:4770-4780. (Pubitemid 43882628)
45. Burgener A, Boutilier J, Wachihi C, Kimani J, Carpenter M, Westmacott G, Cheng K, Ball TB, Plummer F: Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J Proteome Res 2008, 7:4446-4454.
46. Takamatsu H, Okuno T, Kumanogoh A: Regulation of immune cell responses by semaphorins and their receptors. Cell Mol Immunol 2010, 7:83-88.
47. Takegahara N, Kumanogoh A, Kikutani H: Semaphorins: A new class of immunoregulatory molecules. Philos Trans R Soc Lond B Biol Sci 2005, 360:1673-1680. (Pubitemid 43997815)
48. Moser GJ, Foley J, Burnett M, Goldsworthy TL, Maronpot R: Furan-induced dose-response relationships for liver cytotoxicity, cell proliferation, and tumorigenicity (furan-induced liver tumorigenicity). Exp Toxicol Pathol 2009, 61:101-111.
49. Bian YL, Qi YX, Yan ZQ, Long DK, Shen BR, Jiang ZL: A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor. Eur J Cell Biol 2008, 87:101-110.
50. Kwon KB, Park EK, Ryu DG, Park BH: D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells. Exp Mol Med 2002, 34:32-37.
51. Wojcik C, Rowicka M, Kudlicki A, Nowis D, McConnell E, Kujawa M, De Martino GN: Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol Biol Cell 2006, 17:4606-4618. (Pubitemid 44665732)
52. Tschopp J, Martinon F, Burns K: NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003, 4:95-104. (Pubitemid 36172693)
53. Martinon F, Mayor A, Tschopp J: The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265.
54. Munoz LE, Frey B, Pausch F, Baum W, Mueller RB, Brachvogel B, Poschl E, Rodel F, von der Mark K, Herrmann M, Gaipl US: The role of annexin A5 in the modulation of the immune response against dying and dead cells. Curr Med Chem 2007, 14:271-277.
55. Seo S, Baye LM, Schulz NP, Beck JS, Zhang Q, Slusarski DC, Sheffield VC: BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly. Proc Natl Acad Sci USA 2010, 107:1488-1493.
56. Blais DR, Brulotte M, Qian Y, Belanger S, Yao SQ, Pezacki JP: Activity-based proteome profiling of hepatoma cells during hepatitis C virus replication using protease substrate probes. J Proteome Res 2010, 9:912-923.
57. Van der meeren AM, Gomez CE, Patino C, Domingo-Gil E, Guerra S, Gonzalez JM, Esteban M: Subcellular forms and biochemical events triggered in human cells by HCV polyprotein expression from a viral vector. Virol J 2008, 5:102.
58. Sun Young Yoon J-MK, Jung-Hwa O, Yeo-Jin J, Dong-Seok L, Joo Heon K, Jong Young C, Byung Min A, Sangsoo K, Hyang-Sook Y, Yong Sung K, Nam-Soon K: Gene expression profiling of human HBV- And/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. International Journal of Oncology 2006, 29:315-327.
59. Shao RX, Hoshida Y, Otsuka M, Kato N, Tateishi R, Teratani T, Shiina S, Taniguchi H, Moriyama M, Kawabe T, Omata M: Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients. World J Gastroenterol 2005, 11:1995-1999. (Pubitemid 40520999)